Results 171 to 180 of about 73,909 (338)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 654-666, October 2025.
ABSTRACT Background Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy.
Eugene Jeong, Aditi Shendre, Yu Su, Xingyi Guo, Lang Li, You Chen   +5 more
wiley   +1 more source

Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs [PDF]

, 1994
Luis A. Garcı́a Rodrı́guez, Hershel Jick   +1 more
openalex   +1 more source

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 667-676, October 2025.
ABSTRACT Background Drug safety has historically been understudied in pediatric populations, rendering them “therapeutic orphans.” Pediatric drug indications and dosages are often inferred by extrapolating safety, efficacy, and dosing data from adult studies, leading to widespread off‐label use.
Saurabh Rahurkar, Jiayi Ouyang, Pallavi Jonnalagadda, Xiaofu Liu, Shijun Zhang, Chien‐Wei Chiang, Lei Wang, Aditi Shendre, Lang Li   +8 more
wiley   +1 more source

Inappropriate use of proton-pump inhibitors and fragility fracture risk. A preliminary study [PDF]

, 2015
Introducción: Los inhibidores de la bomba de protones (IBP) son fármacos ampliamente utilizados, si bien esto conlleva a un sobreuso que no es acorde con las indicaciones aceptadas en España y en el resto de Europa.
Gómez de Tejada Romero, María Jesús
core  

Clopidogrel with or without omeprazole in coronary artery disease.

New England Journal of Medicine, 2010
Deepak L. Bhatt, B. Cryer, C. Contant, Marc Cohen, Á. Lanas, T. Schnitzer, T. Shook, P. Lapuerta, M. Goldsmith, L. Laine, B. Scirica, S. Murphy, C. Cannon   +12 more
semanticscholar   +1 more source

A study of the interaction of omeprazole and warfarin in anticoagulated patients. [PDF]

, 1992
Peter Unge, LE Svedberg, Ann Nordgren, Henry Blom, Tommy Andersson, P O Lagerström, JP Idström   +6 more
openalex   +1 more source

The Use of Proton Pump Inhibitors Among Adults in Norway—A Nationwide Drug Utilization Study

Pharmacology Research &Perspectives, Volume 13, Issue 5, October 2025.
A nationwide study covering the years 2009–2022 explored trends in proton pump inhibitor use and possible explanations for their increase. ABSTRACT The use of proton pump inhibitors (PPIs) has increased in Western countries over several decades, and there is concern about unsubstantiated indications and effects of long‐term use.
Reidar Fossmark, Sveinung Molnes, Liv Sagatun, Øyvind Salvesen, Olav Spigset   +4 more
wiley   +1 more source

Medication‐Related Osteonecrosis of the Jaws in Patients on Antiresorptive Medication With Dental Implants. A Scoping Review

Clinical Oral Implants Research, Volume 36, Issue 10, Page 1173-1201, October 2025.
ABSTRACT Objectives Patients receiving antiresorptive medication (AR) for osteoporosis or cancer are at risk of medication‐related osteonecrosis of the jaws (MRONJ), especially after surgical procedures. Dental implant (DI) placement in high‐dose AR (HDAR) patients is widely discouraged, and thorough counseling is recommended for low‐dose AR (LDAR ...
Sanne Werner Moeller Andersen, Nishma Vandvig Hindocha, Iben Poulsen, Henning Schliephake, Simon Storgård Jensen   +4 more
wiley   +1 more source

Enhanced clearing ofHelicobacter pyloriafter omeprazole plus roxithromycin treatment [PDF]

, 1991
Luigina Cellini, Leonardo Marzio, Arturo Di Girolamo, Nerino Allocati, Laurino Grossi, B Dainelli   +5 more
openalex   +1 more source

Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children

Clinical and Translational Science, Volume 18, Issue 10, October 2025.
ABSTRACT Pharmacogenomic (PGx) testing is increasingly utilized to guide psychiatric medication selection and dosing, yet real‐world characterizations of test ordering and clinical implications remain understudied. Additionally, the extent to which psychiatry‐focused PGx results inform prescribing beyond mental health medications is unclear. This study
Lusi Zhang, Anthony J. Tholkes, Kaliya C. Jones, Laylia J. Yang, Gretchen K. Sieger, Kathryn R. Cullen, Meredith L. Gunlicks‐Stoessel, Pawel Mroz, Joel F. Farley, Steven G. Johnson, Jeffrey R. Bishop   +10 more
wiley   +1 more source